10x Genomics Inc. (TXG)
NASDAQ: TXG
· Real-Time Price · USD
13.96
0.39 (2.87%)
At close: Sep 05, 2025, 3:59 PM
13.95
-0.07%
Pre-market: Sep 08, 2025, 05:04 AM EDT
10x Genomics Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumables Revenue | 122.19M | 115.36M | 256.89M | 126.2M | 123.36M | 110.33M | 140.31M | 114.37M | 112.49M | 112.38M | 131.6M | 108.11M | 97.93M | 97.95M | 122.4M | 106.12M | 97.15M | 93.08M | 96.54M | 60.56M | 34.16M | 61.43M | 157.13M | 49.74M |
| Consumables Revenue Growth | +5.92% | -55.10% | +103.55% | +2.30% | +11.81% | -21.37% | +22.68% | +1.68% | +0.10% | -14.60% | +21.73% | +10.39% | -0.02% | -19.97% | +15.34% | +9.23% | +4.37% | -3.58% | +59.41% | +77.25% | -44.38% | -60.91% | +215.88% | n/a |
| Instruments Revenue | 14.5M | 14.81M | 48.21M | 19.06M | 23.85M | 25.45M | 38.4M | 34.94M | 30.95M | 19.18M | 2.3M | 20.9M | 14.74M | 14.43M | 1.78M | 17.12M | 16.88M | 11.13M | 1.66M | 9.68M | 7.29M | 1.34M | 2.98M | 1.08M |
| Instruments Revenue Growth | -2.15% | -69.27% | +152.97% | -20.11% | -6.29% | -33.71% | +9.89% | +12.88% | +61.43% | +732.65% | -88.98% | +41.82% | +2.13% | +710.16% | -89.60% | +1.45% | +51.70% | +569.37% | -82.82% | +32.71% | +445.73% | -55.24% | +175.12% | n/a |
| Licensing And Royalty Revenue Revenue | 27.75M | 17.06M | 13.03M | 6.39M | 5.89M | 5.22M | 5.27M | 4.33M | 3.38M | 2.73M | n/a | 2.07M | 1.94M | 2.12M | n/a | 2.06M | 1.82M | 1.62M | n/a | 1.58M | 1.45M | n/a | n/a | n/a |
| Licensing And Royalty Revenue Revenue Growth | +62.67% | +30.97% | +103.72% | +8.56% | +12.88% | -0.93% | +21.67% | +28.23% | +23.62% | n/a | n/a | +6.55% | -8.41% | n/a | n/a | +13.19% | +12.49% | n/a | n/a | +9.24% | n/a | n/a | n/a | n/a |
| Product And Service Revenue Revenue | 145.16M | 137.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Product And Service Revenue Revenue Growth | +5.32% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Service Revenue | 8.47M | 7.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Service Revenue Growth | +10.76% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas Revenue | 106.16M | 90.57M | 87.22M | 87.82M | 93.09M | 79.63M | 103.84M | 99.01M | 91.54M | 78.8M | 13.94M | 9.79M | 9.03M | 13.52M | 19.35M | 10.19M | 8.43M | 11.2M | 14.43M | 8.69M | 7.63M | 11M | 7.05M |
| Americas Revenue Growth | +17.21% | +3.84% | -0.68% | -5.66% | +16.90% | -23.32% | +4.88% | +8.16% | +16.18% | +465.29% | +42.37% | +8.48% | -33.22% | -30.13% | +89.92% | +20.83% | -24.75% | -22.34% | +66.04% | +13.91% | -30.64% | +56.07% | n/a |
| Asia-Pacific, Excluding China Revenue | 8.85M | 15.54M | 13.36M | 10.95M | 8.91M | 12.73M | 17.8M | 10.18M | 11.28M | 13.04M | 43M | 15.77M | 9.09M | 20.76M | 34.73M | 19.06M | 12.87M | 23.64M | 32.9M | 15.5M | 11.71M | 13.16M | 12.14M |
| Asia-Pacific, Excluding China Revenue Growth | -43.06% | +16.25% | +22.03% | +22.87% | -29.99% | -28.48% | +74.80% | -9.69% | -13.51% | -69.68% | +172.62% | +73.58% | -56.23% | -40.22% | +82.19% | +48.07% | -45.54% | -28.13% | +112.27% | +32.28% | -10.97% | +8.42% | n/a |
| China Revenue | 23.17M | 16.88M | 14.61M | 15.03M | 13.74M | 13.92M | 11.75M | 12.43M | 12.76M | 14.03M | 13.67M | 27.93M | 25.61M | 20.53M | 12.27M | 25.82M | 28.77M | 19.17M | n/a | n/a | n/a | n/a | n/a |
| China Revenue Growth | +37.24% | +15.57% | -2.81% | +9.40% | -1.34% | +18.52% | -5.49% | -2.54% | -9.09% | +2.64% | -51.05% | +9.06% | +24.72% | +67.40% | -52.50% | -10.26% | +50.09% | n/a | n/a | n/a | n/a | n/a | n/a |
| Emea Revenue | 34.73M | 31.89M | 49.83M | 37.85M | 37.36M | 34.72M | 50.59M | 32.02M | 31.25M | 28.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Emea Revenue Growth | +8.90% | -35.99% | +31.64% | +1.31% | +7.61% | -31.37% | +58.00% | +2.47% | +9.94% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 74.43M | 89.73M | 93.83M | 81.7M | 83.04M | 84.67M | 86.13M | 82.42M | 91.51M | 83.28M | 78.89M | 73.4M | 79.34M | 66.67M | 69.88M | 62.08M | 68.7M | 56.9M | 55.97M | 51.55M | 44.42M | 50.39M | 38.76M | 32.61M | 32.57M | 26.89M | 26.91M | 19.11M | 21.2M | 20.96M |
| Selling, General, and Administrative Revenue Growth | -17.04% | -4.37% | +14.84% | -1.61% | -1.93% | -1.68% | +4.50% | -9.94% | +9.88% | +5.57% | +7.47% | -7.48% | +18.99% | -4.59% | +12.57% | -9.65% | +20.73% | +1.66% | +8.58% | +16.06% | -11.85% | +30.01% | +18.83% | +0.13% | +21.11% | -0.05% | +40.80% | -9.86% | +1.15% | n/a |
| Research and Development Revenue | 61.22M | 64.25M | 66.97M | 66.17M | 62.92M | 68.64M | 55.55M | 107.91M | 71.46M | 67.1M | 63.61M | 67.29M | 70.69M | 64.08M | 61.88M | 54.58M | 53.4M | 41.88M | 39.7M | 30.14M | 27.54M | 25.99M | 27.89M | 22.21M | 18.03M | 14.96M | 13.08M | 11.09M | 11.44M | 14.79M |
| Research and Development Revenue Growth | -4.70% | -4.07% | +1.20% | +5.17% | -8.33% | +23.56% | -48.52% | +51.01% | +6.50% | +5.48% | -5.46% | -4.80% | +10.31% | +3.55% | +13.38% | +2.21% | +27.50% | +5.49% | +31.72% | +9.47% | +5.94% | -6.80% | +25.58% | +23.15% | +20.51% | +14.41% | +18.00% | -3.14% | -22.62% | n/a |